select
search
Proof Top 200

Q&A


Please sign into your My AccessPharmacy account to take a test. Don't have a free My AccessPharmacy account? Create one now.

Select the number of questions you'd like from each topic and click 'start test.' (Where do the test questions come from?)

Display Q&A from:


minus Clinical Sciences
of 191 from Drug Information
of 65 from Literature Evaluation and Research Design
of 28 from Medication Dispensing and Distribution Systems
of 20 from Medication Safety
of 193 from Patient Assessment: History, Physical, and Laboratory Evaluation
of 1971 from Pharmacotherapy
of 178 from Pharmacy Practice and Pharmaceutical Care
of 99 from Special Populations: Pharmaceutical Care
minus Pharmaceutical Sciences
of 203 from Bioanalysis and Clinical Chemistry
of 69 from Extemporaneous Compounding, Parenteral Products, and Enteral Products
of 116 from Medicinal Chemistry
of 243 from Pharmaceutics and Biopharmaceutics
of 17 from Pharmacogenomics and Pharmacogenetics
of 45 from Pharmacognosy, Alternative, and Complementary Treatments
of 118 from Pharmacokinetics
of 1046 from Pharmacology
of 188 from Toxicology
minus Social, Behavioral, & Administrative Pharmacy Sciences
of 43 from Economics and Pharmacoeconomics
of 25 from Ethics
of 0 from Health Care Delivery Systems
of 16 from History of Pharmacy
of 162 from Pharmacoepidemiology
of 36 from Pharmacy Law and Regulatory Affairs
of 23 from Practice Management
of 47 from Professional Communication
of 38 from Social and Behavioral Aspects of Practice
minus Basic Biomedical Sciences
of 399 from Anatomy and Physiology
of 177 from Biochemistry and Biotechnology
of 99 from Biostatistics
of 46 from Immunology
of 136 from Microbiology
of 40 from Molecular Biology and Genetics
of 330 from Pathology and Pathophysiology
Select the number of questions you'd like from each topic and click 'start test.' The Organ System quiz questions are compiled from Pharmacotherapy: A Pathophysiologic Approach, 8e.

minus Cardiovascular Disorders
of 5 from Cardiovascular Testing
of 3 from Cardiopulmonary Resuscitation
of 91 from Hypertension
of 44 from Systolic Heart Failure
of 14 from Ischemic Heart Disease
of 18 from Acute Coronary Syndromes
of 16 from Arrhythmias
of 16 from Diastolic Heart Failure and the Cardiomyopathies
of 28 from Venous Thromboembolism
of 16 from Stroke
of 42 from Dyslipidemia
of 18 from Peripheral Arterial Disease
of 19 from Shock, Use of Vasopressors and Inotropes in the Pharmacotherapy of
of 7 from Shock, Hypovolemic
of 16 from Cardiac Arrest
of 14 from Acute Decompensated Heart Failure
minus Dermatologic Disorders
of 15 from Dermatologic Drug Reactions and Common Skin Conditions
of 60 from Acne Vulgaris
of 22 from Psoriasis
of 17 from Atopic Dermatitis
minus Endocrinologic Disorders
of 78 from Diabetes Mellitus
of 17 from Thyroid Disorders
of 3 from Adrenal Gland Disorders
of 17 from Pituitary Gland Disorders
minus Gastrointestinal Disorders
of 16 from Gastrointestinal Tract Evaluation
of 27 from Gastroesophageal Reflux Disease
of 22 from Peptic Ulcer Disease
of 19 from Inflammatory Bowel Disease
of 14 from Nausea and Vomiting
of 37 from Diarrhea, Constipation, and Irritable Bowel Syndrome
of 16 from Portal Hypertension and Cirrhosis
of 6 from Liver Disease, Drug-Induced
of 16 from Pancreatitis
of 18 from Hepatitis, Viral
of 16 from Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity
of 15 from Celiac Disease
minus Gynecologic Disorders
of 23 from Pregnancy and Lactation: Therapeutic Considerations
of 17 from Contraception
of 15 from Menstruation-Related Disorders
of 12 from Endometriosis
of 16 from Hormone Therapy in Women
minus Hematologic Disorders
of 16 from Anemias
of 15 from Coagulation Disorders
of 22 from Sickle Cell Disease
of 16 from Hematologic Disorders, Drug-Induced
minus Immunologic Disorders
of 9 from Immune System Evaluation
of 15 from Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases
of 14 from Allergic and Pseudoallergic Drug Reactions
of 19 from Solid-Organ Transplantation
minus Infectious Diseases
of 19 from Laboratory Tests to Direct Antimicrobial Pharmacotherapy
of 30 from Antimicrobial Regimen Selection
of 18 from Central Nervous System Infections
of 26 from Respiratory Tract Infections, Lower
of 25 from Respiratory Tract Infections, Upper
of 20 from Skin and Soft-Tissue Infections
of 19 from Endocarditis, Infective
of 49 from Tuberculosis
of 15 from Gastrointestinal Infections and Enterotoxigenic Poisonings
of 18 from Intraabdominal Infections
of 19 from Parasitic Diseases
of 15 from Urinary Tract Infections and Prostatitis
of 19 from Sexually Transmitted Diseases
of 15 from Bone and Joint Infections
of 21 from Severe Sepsis and Septic Shock
of 15 from Fungal Infections, Superficial
of 21 from Fungal Infections, Invasive
of 15 from Immunocompromised Patients, Infections in
of 17 from Antimicrobial Prophylaxis in Surgery
of 73 from Vaccines, Toxoids, and Other Immunobiologics
of 62 from Human Immunodeficiency Virus Infection
of 44 from Influenza
minus Neurologic Disorders
of 21 from Neurologic Illness Evaluation
of 15 from Multiple Sclerosis
of 43 from Epilepsy
of 24 from Status Epilepticus
of 15 from Brain Injury, Acute Management
of 85 from Parkinson's Disease
of 45 from Pain Management
of 16 from Headache Disorders
of 50 from Alzheimers Disease
minus Nutrition Disorders
of 16 from Nutrition Status and Nutrition Requirements Assessment
of 43 from Parenteral Nutrition
of 38 from Enteral Nutrition
of 13 from Nutritional Considerations in Major Organ Failure
of 51 from Obesity
of 16 from Medication Administration Considerations with Specialized Nutrition Support
minus Oncologic Disorders
of 70 from Cancer Treatment and Chemotherapy
of 42 from Breast Cancer
of 32 from Lung Cancer
of 36 from Colorectal Cancer
of 14 from Prostate Cancer
of 15 from Lymphomas
of 20 from Ovarian Cancer
of 5 from Hematopoietic Stem Cell Transplantation
of 2 from Multiple Myeloma
of 15 from Myelodysplastic Syndromes
of 15 from Renal Cell Carcinoma
minus Ophthalmic and Otolaryngologic Disorders
of 21 from Glaucoma
of 20 from Allergic Rhinitis
minus Psychiatric Disorders
of 16 from Psychiatric Illness Evaluation
of 16 from Childhood Disorders
of 15 from Eating Disorders
of 15 from Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens
of 15 from Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
of 36 from Schizophrenia
of 36 from Major Depressive Disorder
of 26 from Bipolar Disorder
of 16 from Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
of 15 from Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
of 17 from Sleep Disorders
of 15 from Disorders Associated with Intellectual Disabilities
minus Renal Disorders
of 19 from Clinical Assessment of Kidney Function
of 43 from Acute Renal Injury
of 15 from Chronic Kidney Disease: Progression-Modifying Therapies
of 15 from Chronic Kidney Disease: Management of Complications
of 20 from Hemodialysis and Peritoneal Dialysis
of 15 from Kidney Disease, Drug-Induced
of 21 from Glomerulonephritis
of 22 from Drug Therapy Individualization for Patients with Renal Insufficiency
of 12 from Disorders of Sodium and Water Homeostasis
of 17 from Disorders of Potassium and Magnesium Homeostasis
of 22 from Acid-Base Disorders
of 14 from Disorders of Calcium and Phosphorus Homeostasis
minus Respiratory Disorders
of 1 from Pulmonary Function Testing
of 92 from Asthma
of 70 from Chronic Obstructive Pulmonary Disease
of 16 from Pulmonary Diseases, Drug-Induced
of 31 from Cystic Fibrosis
of 16 from Pulmonary Arterial Hypertension
minus Rheumatologic Disorders
of 16 from Osteoporosis and Other Metabolic Bone Diseases
of 11 from Rheumatoid Arthritis
of 40 from Osteoarthritis
of 16 from Gout and Hyperuricemia
minus Urologic Disorders
of 42 from Erectile Dysfunction
of 30 from Benign Prostatic Hyperplasia
of 19 from Incontinence, Urinary
Top 300 Drugs Review
From the LANGE 2012-2013 Top 300 Pharmacy Drug Cards by Jill M. Kolesar, Lee Vermeulen
Review the Top 300 drugs by drug name. Test yourself on drug topic information specific to the drug and reveal information by clicking on the topic.
top200 Drug Quiz
Test yourself on the top 200 drugs
It’s a race to the finish! Compare your performance to that of your peers. Comparison will be based on speed and correct answers. Compare yourself against your first performance by taking the test again.

What are the top 200 drugs?
This quiz is best taken with a high-speed internet connection. A slower connection may affect your results.
Therapeutic Drug Class Tier 1
Brand/Generic and Classifications
Tier 2
Available Dosage Forms and FDA Indications
Tier 3
Dosage and Patient Counseling
Analgesic and Anti-
Inflammatory Agents
Take the challenge Take the challenge Take the challenge
Antidiabetic Agents Take the challenge Take the challenge Take the challenge
Anti-Infective Agents Take the challenge Take the challenge Take the challenge
Cardiovascular Agents Take the challenge Take the challenge Take the challenge
Gastrointestinal Agents Take the challenge Take the challenge Take the challenge
Hormone and Electrolyte Agents Take the challenge Take the challenge Take the challenge
Miscellaneous Agents Take the challenge Take the challenge Take the challenge
Neurologic Agents Take the challenge Take the challenge Take the challenge
Respiratory Agents Take the challenge Take the challenge Take the challenge
A note about Tiers:
Tiers correspond to PharmD 4-year program. Each tier should test content appropriate to the corresponding year.
  • Tier 1=Year 2
  • Tier 2=Year 3
  • Tier 3=Year 4
Editor:
Gina Carbonara Baugh, PharmD
Clinical Assistant Professor
Director of Introductory Pharmacy Practice Experiences
WVU School of Pharmacy
Drug classification system courtesy of Sigler Drug Cards.
SFI logo